tiprankstipranks
Advertisement
Advertisement
Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c)
PremiumThe FlyTenaya Therapeutics reports Q1 EPS (9c), consensus (9c)
1M ago
Tenaya Therapeutics Duchenne muscular dystrophy treatment granted orphan status
Premium
The Fly
Tenaya Therapeutics Duchenne muscular dystrophy treatment granted orphan status
2M ago
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
Premium
Ratings
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
2M ago
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
3M ago
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
Premium
Ratings
TN-301: Differentiated HDAC6 Inhibitor Offering Dual Skeletal and Cardiac Benefit in DMD with Multiple Near-Term Catalysts
3M ago
Tenaya Therapeutics presents preclinical data evaluating TN-301
Premium
The Fly
Tenaya Therapeutics presents preclinical data evaluating TN-301
3M ago
e.l.f., Crown Castle, DoorDash, Stag, Tenaya Shake-Up
PremiumWeekend Updatese.l.f., Crown Castle, DoorDash, Stag, Tenaya Shake-Up
3M ago
Tenaya Therapeutics Faces Nasdaq Deficiency, Amends Equity Plan
Premium
Company Announcements
Tenaya Therapeutics Faces Nasdaq Deficiency, Amends Equity Plan
4M ago
Tenaya Therapeutics: 2026 Clinical Milestones, FDA Pivotal Pathway, and Strengthened Balance Sheet Support Buy Rating
Premium
Ratings
Tenaya Therapeutics: 2026 Clinical Milestones, FDA Pivotal Pathway, and Strengthened Balance Sheet Support Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100